Trials / Available
AvailableNCT06188975
Expanded Access to ABBV-CLS-484
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Calico Life Sciences LLC · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-CLS-484 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DRUG: ABBV-CLS-484 |
Timeline
- First posted
- 2024-01-03
- Last updated
- 2024-01-03
Source: ClinicalTrials.gov record NCT06188975. Inclusion in this directory is not an endorsement.